Trophic Regulation in T Cell Homeostasis and Disease
Trophic Regulation in T Cell Homeostasis and Disease
批准号:
7103776
负责人:
Jeffrey C. Rathmell
金额:
$38.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-01 至 2011-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Maintenance of lymphoid homeostasis is critical to avert diseases such as autoimmunity, lymphoma, and immunodeficiency. We propose to study a novel mechanism of T cell homeostasis - control of nutrient usage, or trophic level, by regulation of glucose uptake and the glucose transporter, Glut1. Lymphocytes require dynamic regulation of glucose uptake to allow both cell survival in a resting state and robust growth and proliferation in immune responses. We have shown that glucose uptake and metabolism are regulated events that can have a profound impact on T cell survival and function. We show that glucose uptake in both resting and activated T cells is tightly regulated in vitro by the cytokines interleukin 7 (IL7) and interleukin 2 (IL2), respectively. The in vivo signals and signaling mechanisms required for regulation of Glut1 and the effects of altered glucose uptake on T cell size, survival, and function, however, remain uncertain. In this application, we propose to address these issues to bridge the fields of immunology and cellular metabolism. We will: (1) Determine the in vivo role of IL7 in regulation of Glut1 expression and intracellular trafficking by adoptive transfer of T cells into IL7-/- hosts and conditional deletion of IL7R in mature T cells. (2) Identify signaling mechanisms that regulate Glut1 expression and cell surface localization. The PI3K/Akt and Jak/STAT signaling pathways are activated by IL7 and IL2 and these pathways will be analyzed for their role in Glut1 regulation in cell line and primary T cell models using RNAi, transgenic, and knockout approaches. (3) Examine the role of Glut1 expression in T cell development and homeostasis using a T cell specific Glut1 transgenic mouse model and in vitro RNAi of Glut1. The ability of Glut1 expression to modulate lymphoma and autoimmunity observed in Akt transgenic mice will be investigated to determine how altered glucose uptake may affect disease. Together, these experiments will identify signals and signaling mechanisms that regulate T cell glucose uptake and determine the role of glucose uptake in T cell survival, activation, and diseases of the immune system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic barriers to T cell activation in clear cell renal cell carcinoma
-
批准号:10532599
-
项目类别:
-
资助金额:$55.33万
-
财政年份:2018
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Metabolic Barriers to T Cell Activation in Clear Cell Renal Cell Carcinoma
-
批准号:10375526
-
项目类别:
-
资助金额:$43.05万
-
财政年份:2018
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
-
批准号:10380136
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2015
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
-
批准号:9269283
-
项目类别:
-
资助金额:$37.91万
-
财政年份:2015
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
-
批准号:9889950
-
项目类别:
-
资助金额:$38.93万
-
财政年份:2015
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
-
批准号:8890911
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2015
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
-
批准号:9126664
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2015
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
-
批准号:10586461
-
项目类别:
-
资助金额:$40.73万
-
财政年份:2015
-
负责人:Jeffrey C. Rathmell
-
依托单位:
B cell metabolism in activation and autoantibody production
-
批准号:8561193
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2013
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Glucose Transport in Regulation of T Cell Activation and Inflammation
-
批准号:8513581
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2012
-
负责人:Jeffrey C. Rathmell
-
依托单位:
T cell metabolism as a determinant of differentiation in allergic asthma
-
批准号:8448682
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2011
-
负责人:Jeffrey C. Rathmell
-
依托单位:
T cell metabolism as a determinant of differentiation in allergic asthma
-
批准号:9096333
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2011
-
负责人:Jeffrey C. Rathmell
-
依托单位:
T cell metabolism as a determinant of differentiation in allergic asthma
-
批准号:8094015
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2011
-
负责人:Jeffrey C. Rathmell
-
依托单位:
T cell metabolism as a determinant of differentiation in allergic asthma
-
批准号:8645712
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2011
-
负责人:Jeffrey C. Rathmell
-
依托单位:
T cell metabolism as a determinant of differentiation in allergic asthma
-
批准号:8255492
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2011
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Glucose metabolism and cell death in cancer
-
批准号:8004097
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2007
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Glucose metabolism and cell death in cancer
-
批准号:7753198
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2007
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Glucose metabolism and cell death in cancer
-
批准号:7391722
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2007
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Glucose metabolism and cell death in cancer
-
批准号:7259909
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2007
-
负责人:Jeffrey C. Rathmell
-
依托单位:
Glucose metabolism and cell death in cancer
-
批准号:7554136
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2007
-
负责人:Jeffrey C. Rathmell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
-
批准号:82370796
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:蒋怡然
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
GPSM1介导Ca2+循环-II型肌球蛋白网络调控脂肪产热及代谢稳态的机制研究
-
批准号:82370879
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:严婧
-
依托单位:
PRRC2在eIF3调控的翻译过程中的分子机制及其对肌肉健康的影响
-
批准号:32100620
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:林英英
-
依托单位:
SLC38A6通过调控天冬氨酸介导的嘧啶合成促进肝癌生长的机制研究
-
批准号:32100626
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:秦望舒
-
依托单位:
磷脂酰胆碱在LET-607寿命决定通路中的功能与机制研究
-
批准号:32070754
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:唐海清
-
依托单位:
Hippo信号通路调控肝星状细胞活化机制研究
-
批准号:32070789
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:葛高翔
-
依托单位:
Cav1.2在束缚应激大鼠结肠平滑肌细胞钙稳态失衡中的作用机制
-
批准号:30840045
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2008
-
负责人:李俊霞
-
依托单位: